Home / Blog / What ISO 11607-3:2026 Means for Medical Device Manufacturers
Blog
November 16, 2026

What ISO 11607-3:2026 Means for Medical Device Manufacturers

Share

When revisions to standards are released a lot of questions can arise. Do you need to change your approach? Will existing validations need to be repeated? With the publications of ISO 11607-3:2026, medical device manufacturers may be wondering what this new part means for their packaging processes.  

Part 3 focuses on the development work that takes place before validation. It gives manufacturers a more structured way to consider the materials, equipment, and process conditions that can affect sealing performance. 

We spoke with Sean Coast to discuss where Part 3 fits, what manufacturers should consider, and why its publication doesn’t necessarily mean starting over. 

What does ISO 11607 part 3 cover? 

ISO 11607-3:2026 establishes requirements for developing heat sealing processes used to produce packaging for terminally sterilized medical devices. It covers preformed sterile barrier systems and is intended to be used before process validation.  

“Part 3 helps address a gap between knowing a process needs to be validated and understanding what to consider before beginning that work,” says Sean Coast, Staff Engineer at PCL. While experienced engineers may already recognize many of these considerations, having them laid out can provide a useful starting point for someone who is newer to packaging validation. 

Do existing processes need to be revalidated? 

Manufacturers do not need to repeat validation simply because part 3 has been published, provided their existing heat sealing processes have successfully met the validation requirements of ISO 11607-2. The focus is on the processes that have not yet been validated. 

That distinction matters when deciding what to do next. A manufacturer preparing a new process for validation should review Part 3 during development. For an existing validated process, teams should continue to manage changes and evaluate any need for revalidation through their established quality procedures.  

How should manufacturers approach their next project? 

Start by reviewing Part 3 alongside your planned development activities. Consider the materials you will use, the equipment and tooling involved, and the factors that could affect sealing consistency before finalizing your validation approach.  

For newer engineers, this can help make the starting point clearer. For experienced teams, it provides a useful opportunity to review established practices and identify anything that needs more attention before validation begins. 

Key Takeaways 

ISO 11607-3:2026 focuses on heat sealing process development before validation. Manufacturers planning new processes should review its requirements early and consider how things like materials and equipment performance could affect their approach. Existing successful validations do not need to be repeated solely because Part 3 has been published. Understanding the guidance provided by Part 3 can help teams plan their next project with greater clarity.  

 

If you found this helpful, we share insights like this on LinkedIn every week. Follow us there to keep the conversation going.

You can also explore more resources and services on our website.

Contact Form

Company Address(Required)

Discover more articles

Blog

What ISO 11607-3:2026 Means for Medical Device Manufacturers

Read More

Blog

Arthritis vs. Emergency Drugs: How Therapeutic Use Shapes Prefilled Syringe and Autoinjector Testing

Read More

Blog

Packaging Compliance Labs Adds State-of-the-art Instron Testing Platforms to New Pharma Lab

Read More

Blog

ISO 11040-8:2026 Revision: What’s Changed for Prefilled Syringes?

Read More

Blog

Packaging Compliance Labs Enters Pharmaceutical Testing Market with Dedicated Lab and Expert Leadership

Read More

Blog

A Guide to Gamma and EO Sterilization for Medical Devices

Read More